nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—Localized exfoliation—Bleomycin—lymphatic system cancer	0.0545	0.0545	CcSEcCtD
Magnesium salicylate—Epigastric pain—Mitoxantrone—lymphatic system cancer	0.0247	0.0247	CcSEcCtD
Magnesium salicylate—Hypocalcaemia—Fludarabine—lymphatic system cancer	0.0219	0.0219	CcSEcCtD
Magnesium salicylate—Hearing impaired—Fludarabine—lymphatic system cancer	0.021	0.021	CcSEcCtD
Magnesium salicylate—Burning sensation—Carmustine—lymphatic system cancer	0.0185	0.0185	CcSEcCtD
Magnesium salicylate—Oesophagitis—Fludarabine—lymphatic system cancer	0.0183	0.0183	CcSEcCtD
Magnesium salicylate—Stupor—Carmustine—lymphatic system cancer	0.0172	0.0172	CcSEcCtD
Magnesium salicylate—Deafness—Fludarabine—lymphatic system cancer	0.0163	0.0163	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.0147	0.0147	CcSEcCtD
Magnesium salicylate—Tinnitus—Mechlorethamine—lymphatic system cancer	0.0145	0.0145	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Bleomycin—lymphatic system cancer	0.014	0.014	CcSEcCtD
Magnesium salicylate—Hypocalcaemia—Mitoxantrone—lymphatic system cancer	0.013	0.013	CcSEcCtD
Magnesium salicylate—Depressed level of consciousness—Carmustine—lymphatic system cancer	0.0124	0.0124	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Carmustine—lymphatic system cancer	0.0122	0.0122	CcSEcCtD
Magnesium salicylate—Sweating—Teniposide—lymphatic system cancer	0.0122	0.0122	CcSEcCtD
Magnesium salicylate—Ecchymosis—Mitoxantrone—lymphatic system cancer	0.0108	0.0108	CcSEcCtD
Magnesium salicylate—Flushing—Teniposide—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Magnesium salicylate—Epistaxis—Fludarabine—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Magnesium salicylate—Anorexia—Mechlorethamine—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Magnesium salicylate—Deafness—Vincristine—lymphatic system cancer	0.00993	0.00993	CcSEcCtD
Magnesium salicylate—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00959	0.00959	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00951	0.00951	CcSEcCtD
Magnesium salicylate—Burning sensation—Methotrexate—lymphatic system cancer	0.00855	0.00855	CcSEcCtD
Magnesium salicylate—Confusional state—Teniposide—lymphatic system cancer	0.0082	0.0082	CcSEcCtD
Magnesium salicylate—Oedema—Teniposide—lymphatic system cancer	0.00813	0.00813	CcSEcCtD
Magnesium salicylate—Stupor—Methotrexate—lymphatic system cancer	0.00795	0.00795	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.0079	0.0079	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00786	0.00786	CcSEcCtD
Magnesium salicylate—Pruritus—Mechlorethamine—lymphatic system cancer	0.0078	0.0078	CcSEcCtD
Magnesium salicylate—Anorexia—Teniposide—lymphatic system cancer	0.00775	0.00775	CcSEcCtD
Magnesium salicylate—Hypotension—Teniposide—lymphatic system cancer	0.0076	0.0076	CcSEcCtD
Magnesium salicylate—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00755	0.00755	CcSEcCtD
Magnesium salicylate—Confusional state—Fludarabine—lymphatic system cancer	0.00721	0.00721	CcSEcCtD
Magnesium salicylate—Oedema—Fludarabine—lymphatic system cancer	0.00715	0.00715	CcSEcCtD
Magnesium salicylate—Decreased appetite—Teniposide—lymphatic system cancer	0.00707	0.00707	CcSEcCtD
Magnesium salicylate—Vomiting—Mechlorethamine—lymphatic system cancer	0.00701	0.00701	CcSEcCtD
Magnesium salicylate—Rash—Mechlorethamine—lymphatic system cancer	0.00696	0.00696	CcSEcCtD
Magnesium salicylate—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00695	0.00695	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00691	0.00691	CcSEcCtD
Magnesium salicylate—Flushing—Bleomycin—lymphatic system cancer	0.00685	0.00685	CcSEcCtD
Magnesium salicylate—Anorexia—Fludarabine—lymphatic system cancer	0.00681	0.00681	CcSEcCtD
Magnesium salicylate—Weight increased—Mitoxantrone—lymphatic system cancer	0.00681	0.00681	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Teniposide—lymphatic system cancer	0.0067	0.0067	CcSEcCtD
Magnesium salicylate—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00667	0.00667	CcSEcCtD
Magnesium salicylate—Sweating—Vincristine—lymphatic system cancer	0.00656	0.00656	CcSEcCtD
Magnesium salicylate—Nausea—Mechlorethamine—lymphatic system cancer	0.00655	0.00655	CcSEcCtD
Magnesium salicylate—Urticaria—Teniposide—lymphatic system cancer	0.00646	0.00646	CcSEcCtD
Magnesium salicylate—Erythema—Bleomycin—lymphatic system cancer	0.00642	0.00642	CcSEcCtD
Magnesium salicylate—Hallucination—Carmustine—lymphatic system cancer	0.00641	0.00641	CcSEcCtD
Magnesium salicylate—Sweating—Mitoxantrone—lymphatic system cancer	0.00639	0.00639	CcSEcCtD
Magnesium salicylate—Dyspepsia—Fludarabine—lymphatic system cancer	0.00629	0.00629	CcSEcCtD
Magnesium salicylate—Decreased appetite—Fludarabine—lymphatic system cancer	0.00621	0.00621	CcSEcCtD
Magnesium salicylate—Hallucination—Vincristine—lymphatic system cancer	0.00612	0.00612	CcSEcCtD
Magnesium salicylate—Pain—Fludarabine—lymphatic system cancer	0.00611	0.00611	CcSEcCtD
Magnesium salicylate—Constipation—Fludarabine—lymphatic system cancer	0.00611	0.00611	CcSEcCtD
Magnesium salicylate—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00599	0.00599	CcSEcCtD
Magnesium salicylate—Flushing—Carmustine—lymphatic system cancer	0.00598	0.00598	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00589	0.00589	CcSEcCtD
Magnesium salicylate—Pruritus—Teniposide—lymphatic system cancer	0.00575	0.00575	CcSEcCtD
Magnesium salicylate—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00573	0.00573	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Methotrexate—lymphatic system cancer	0.00567	0.00567	CcSEcCtD
Magnesium salicylate—Erythema—Carmustine—lymphatic system cancer	0.00561	0.00561	CcSEcCtD
Magnesium salicylate—Diarrhoea—Teniposide—lymphatic system cancer	0.00556	0.00556	CcSEcCtD
Magnesium salicylate—Ecchymosis—Methotrexate—lymphatic system cancer	0.00537	0.00537	CcSEcCtD
Magnesium salicylate—Confusional state—Bleomycin—lymphatic system cancer	0.00528	0.00528	CcSEcCtD
Magnesium salicylate—Oedema—Bleomycin—lymphatic system cancer	0.00524	0.00524	CcSEcCtD
Magnesium salicylate—Erythema—Mitoxantrone—lymphatic system cancer	0.00521	0.00521	CcSEcCtD
Magnesium salicylate—Vomiting—Teniposide—lymphatic system cancer	0.00517	0.00517	CcSEcCtD
Magnesium salicylate—Rash—Teniposide—lymphatic system cancer	0.00513	0.00513	CcSEcCtD
Magnesium salicylate—Dermatitis—Teniposide—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Magnesium salicylate—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.0051	0.0051	CcSEcCtD
Magnesium salicylate—Headache—Teniposide—lymphatic system cancer	0.00509	0.00509	CcSEcCtD
Magnesium salicylate—Pruritus—Fludarabine—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Magnesium salicylate—Anorexia—Bleomycin—lymphatic system cancer	0.005	0.005	CcSEcCtD
Magnesium salicylate—Hypotension—Bleomycin—lymphatic system cancer	0.0049	0.0049	CcSEcCtD
Magnesium salicylate—Diarrhoea—Fludarabine—lymphatic system cancer	0.00489	0.00489	CcSEcCtD
Magnesium salicylate—Nausea—Teniposide—lymphatic system cancer	0.00483	0.00483	CcSEcCtD
Magnesium salicylate—Confusional state—Carmustine—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Magnesium salicylate—Oedema—Carmustine—lymphatic system cancer	0.00457	0.00457	CcSEcCtD
Magnesium salicylate—Decreased appetite—Bleomycin—lymphatic system cancer	0.00456	0.00456	CcSEcCtD
Magnesium salicylate—Vomiting—Fludarabine—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Magnesium salicylate—Rash—Fludarabine—lymphatic system cancer	0.00451	0.00451	CcSEcCtD
Magnesium salicylate—Dermatitis—Fludarabine—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Magnesium salicylate—Pain—Bleomycin—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Magnesium salicylate—Headache—Fludarabine—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Magnesium salicylate—Lethargy—Methotrexate—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Magnesium salicylate—Oedema—Vincristine—lymphatic system cancer	0.00437	0.00437	CcSEcCtD
Magnesium salicylate—Anorexia—Carmustine—lymphatic system cancer	0.00436	0.00436	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00432	0.00432	CcSEcCtD
Magnesium salicylate—Confusional state—Mitoxantrone—lymphatic system cancer	0.00429	0.00429	CcSEcCtD
Magnesium salicylate—Hypotension—Carmustine—lymphatic system cancer	0.00427	0.00427	CcSEcCtD
Magnesium salicylate—Oedema—Mitoxantrone—lymphatic system cancer	0.00425	0.00425	CcSEcCtD
Magnesium salicylate—Nausea—Fludarabine—lymphatic system cancer	0.00425	0.00425	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Magnesium salicylate—Shock—Mitoxantrone—lymphatic system cancer	0.00418	0.00418	CcSEcCtD
Magnesium salicylate—Urticaria—Bleomycin—lymphatic system cancer	0.00416	0.00416	CcSEcCtD
Magnesium salicylate—Anorexia—Vincristine—lymphatic system cancer	0.00416	0.00416	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Magnesium salicylate—Hypotension—Vincristine—lymphatic system cancer	0.00408	0.00408	CcSEcCtD
Magnesium salicylate—Somnolence—Carmustine—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Magnesium salicylate—Anorexia—Mitoxantrone—lymphatic system cancer	0.00405	0.00405	CcSEcCtD
Magnesium salicylate—Decreased appetite—Carmustine—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Magnesium salicylate—Hypotension—Mitoxantrone—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Magnesium salicylate—Constipation—Carmustine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Magnesium salicylate—Pain—Carmustine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Magnesium salicylate—Decreased appetite—Vincristine—lymphatic system cancer	0.0038	0.0038	CcSEcCtD
Magnesium salicylate—Somnolence—Mitoxantrone—lymphatic system cancer	0.00378	0.00378	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Carmustine—lymphatic system cancer	0.00377	0.00377	CcSEcCtD
Magnesium salicylate—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Magnesium salicylate—Constipation—Vincristine—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Magnesium salicylate—Pain—Vincristine—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Magnesium salicylate—Asthma—Methotrexate—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Magnesium salicylate—Pruritus—Bleomycin—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Magnesium salicylate—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Magnesium salicylate—Pain—Mitoxantrone—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Magnesium salicylate—Constipation—Mitoxantrone—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Magnesium salicylate—Urticaria—Mitoxantrone—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Magnesium salicylate—Vomiting—Bleomycin—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Magnesium salicylate—Drowsiness—Methotrexate—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Magnesium salicylate—Rash—Bleomycin—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Magnesium salicylate—Dermatitis—Bleomycin—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Magnesium salicylate—Sweating—Methotrexate—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Magnesium salicylate—Epistaxis—Methotrexate—lymphatic system cancer	0.00313	0.00313	CcSEcCtD
Magnesium salicylate—Diarrhoea—Carmustine—lymphatic system cancer	0.00313	0.00313	CcSEcCtD
Magnesium salicylate—Nausea—Bleomycin—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Magnesium salicylate—Dizziness—Carmustine—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Magnesium salicylate—Diarrhoea—Vincristine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Magnesium salicylate—Hepatitis—Methotrexate—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Magnesium salicylate—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Magnesium salicylate—Vomiting—Carmustine—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Magnesium salicylate—Dizziness—Vincristine—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Magnesium salicylate—Rash—Carmustine—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Magnesium salicylate—Dermatitis—Carmustine—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Magnesium salicylate—Headache—Carmustine—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Magnesium salicylate—Tinnitus—Methotrexate—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Magnesium salicylate—Vomiting—Vincristine—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Magnesium salicylate—Rash—Vincristine—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Magnesium salicylate—Dermatitis—Vincristine—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Magnesium salicylate—Headache—Vincristine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Magnesium salicylate—Nausea—Carmustine—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Magnesium salicylate—Vomiting—Mitoxantrone—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Magnesium salicylate—Rash—Mitoxantrone—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Magnesium salicylate—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Magnesium salicylate—Headache—Mitoxantrone—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Magnesium salicylate—Erythema—Methotrexate—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Magnesium salicylate—Nausea—Vincristine—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Magnesium salicylate—Dysgeusia—Methotrexate—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Magnesium salicylate—Nausea—Mitoxantrone—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Magnesium salicylate—Confusional state—Methotrexate—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Magnesium salicylate—Anorexia—Methotrexate—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Magnesium salicylate—Hypotension—Methotrexate—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Magnesium salicylate—Somnolence—Methotrexate—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Magnesium salicylate—Dyspepsia—Methotrexate—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Magnesium salicylate—Decreased appetite—Methotrexate—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Magnesium salicylate—Pain—Methotrexate—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Magnesium salicylate—Urticaria—Methotrexate—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Magnesium salicylate—Pruritus—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Magnesium salicylate—Diarrhoea—Methotrexate—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Magnesium salicylate—Dizziness—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Magnesium salicylate—Vomiting—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Magnesium salicylate—Rash—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Magnesium salicylate—Dermatitis—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Magnesium salicylate—Headache—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Magnesium salicylate—Nausea—Methotrexate—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
